@Chinmoku, I own a few shares in ElectroCore.
ElectroCore, Inc. is a medical device company with a non-invasive vagus nerve stimulation (nVNS) therapy. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems.
The gammaCore Sapphire is a handheld delivery system intended for multi-year use. GammaCore has several applications, including treating
medication overuse neuro trauma in adults.
They have launched e-commerce storefronts in the United Kingdom (UK) and the United States (US). A team then stays in regular contact with the patient, providing further support during the course of the therapy.
In our legacy business channels, we have continued to grow our Department of Veterans Affairs (VA) and Department of Defense (DoD) business in the United States, our National Health Service (NHS) business in the United Kingdom, and our distributor relationships around the world. We plan to continue to invest in growth from these channels as we move through 2022.